Estrogen blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries

Journal of Surgical Research

Volumn 118, Issue 1, 2004, Pages 83-90

  Spencer, Todd A ^a   Chai, Hong ^a   Fu, Weiping ^a   Ramaswami, Ganesh ^a   Cox, Mitchell W ^a   Conklin, Brian S ^a   Lin, Peter H ^a   Lumsden, Alan B ^a   Yao, Qizhi ^a   Chen, Changyi ^a,b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Coronary artery; Endothelial cells; eNOS; Estrogen; Homocysteine; Porcine; Superoxide anion

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; BRADYKININ; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN; FREE RADICAL; HOMOCYSTEINE; NITROPRUSSIDE SODIUM; SUPEROXIDE;

ANIMAL TISSUE; CHEMOLUMINESCENCE; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM LESION; IMMUNOHISTOCHEMISTRY; MEASUREMENT; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTILITY; SWINE; VASODILATATION; VASOMOTOR DISORDER;

ANIMALS; ARTERIES; CORONARY VESSELS; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; ESTRADIOL; HOMOCYSTEINE; IMMUNOHISTOCHEMISTRY; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; STAINING AND LABELING; SUPEROXIDES; SWINE; VASODILATION;

EID: 11144355507     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2004.01.021     Document Type: Conference Paper

References (33)

1. Chen C., Conklin B.S., Ren Z., Zhong D.S. Homocysteine decreases endothelium-dependent vasorelaxation in porcine arteries. J. Vasc. Res. 102:2002;22.
2. McKully K.S. Vascular pathology of homocystinemia Implication for the pathogenesis of arteriosclerosis. Am. J. Pathol. 56:1969;111.
3. Mudd S.H., Levy H.Z., Skouby F. Disorders of transsulfuration. Scriver C.R., Beauchet A., Sly W.S., Valle D. The Metabolic and Molecular Basis of Inherited Disease. Vol 1:1995;1279-1327 McGraw-Hill, New York.
4. Frosst P., Blom H.L., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijtmans L.A., van den Heuvel L.P. A candidate genetic risk factor for vascular disease A common mutation in methylene tetrahydrofolate reductase. Nat. Genet. 10:1995;111.
5. Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowler B., Graham I. Hyperhomocystinemia An independent risk factor for vascular disease. N. Engl. J. Med. 324:1991;1149.
6. Folsom A.R., Nieto F.J., McGovern P.G., Tsai M.Y., Malinow M.R., Eckfeldt J.H., Hess D.L., Davis C.E. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins The Atherosclerosis Risk in Communities (ARIC) study. Circulation. 98:1998;204.
7. McCully K.S. Homocysteine and vascular disease. Nat. Med. 2:1996;386.
8. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N. Engl. J. Med. 337:1997;230.
9. Surowiec S.M., Conklin B.S., Li L.S., Lin P.H., Lumsden A.B., Chen C. A new perfusion culture system used to study human vein. J. Surg. Res. 88:2000;34.
10. Conklin B.S., Surowiec S.M., Ren Z.G., Li J., Zhong D.S., Lumsden A.B., Chen C. Effects of nicotine and cotinine on porcine arterial endothelial cell function. J. Surg. Res. 95:2001;23.
11. Benzuly K.H., Padgett R.C., Kaul S., Peigors D.J., Armstrong M.L., Heistad D.D. Functional improvement precedes structural regression of atherosclerosis. Circulation. 89:1994;1810.
12. Singer H., Peach M. Calcium- and endothelial-mediated vascular smooth muscle relaxation in rabbit aorta. Hypertension. 3:1982;19.
13. Pelc L.R., Gross G.J., Warltier D.C. Mechanism of coronary vasodilation produced by bradykinin. Circulation. 83:1991;2048.
14. Lang D., Kredan M.B., Moat S.J., Hussain S.A., Powell C.A., Bellamy M.F., Powers H.J., Lewis M.J. Homocysteine-induced inhibition of endothelium- dependent relaxation in rabbit aorta. Role for superoxide anions. Arterioscler. Thromb. Vasc. Biol. 20:2000;422.
15. Quere I., Hillaire-Buys D., Brunschwig C., Chapal J., Janbon C., Blayac J.P., Petit P., Loubatieres-Mariani M.M. Effects of homocysteine on acetylcholine- and adenosine-induced vasodilatation of pancreatic vascular bed in rats. Br. J. Pharmacol. 122:1997;351.
16. Lentz S.R., Sobey C.G., Piegors D.J., Bhapatkar M.Y., Faraci F.M., Rene M.M., Heistad D.D. Vascular dysfunction in monkeys with diet-induced hyperhomocystinemia. J. Clin. Invest. 98:1996;24.
17. Watanable M., Osada J., Aratani Y., Kluchman K., Reddick R., Malinow M.R., Maeda N. Mice deficient in cystathionine beta-synthase animal models for mild and severe homocystinemia. Proc. Natl. Acad. Sci. USA. 92:1995;1585.
18. McDowell I.F.W., Lang D. Homocysteine and endothelial dysfunction A link with cardiovascular disease. J. Nutr. 130:2000;369S.
19. Beckman J.S., Beckman T.W., Chen J., Marshall P.M., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Aci. USA. 87:1990;1620.
20. Babior B.M. The NADPH oxidase of endothelial cells. IUBMB Life. 50:2000;267.
21. Wagner A.H., Kohler T., Ruckschloss U., Just I., Hecker M. Improvement of nitric oxide dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler. Thromb. Biol. 20:2000;61.
22. Munzel T., Afanasev I.B., Kleschyov A.L., Harrison D.G. Detection of superoxide in vascular tissues. Arterioscler. Thromb. Vasc. Biol. 22:2002;1761.
23. Tsen C.M., Hsieh C.C., Yen C.H., Lau Y.T. Homocysteine altered ROS generation and NO accumulation in endothelial cells. Chin. J. Physiol. 46:2003;129.
24. Ueland P.M., Refsum H., Stabler S.P., Malinow M.R., Andersson A., Allen R.H. Total homocysteine in plasma or serum methods and clinical applications. Clin. Chem. 39:1993;1764.
25. Grady D., Rubin S.M., Petitti D.B., Fox C.S., Black D., Ettinger B., Ernester V.L., Cummins S.R. Hormone therapy to prevent disease and prolong life in post-menopausal women. Ann. Intern. Med. 117:1992;1016.
26. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 280:1998;605.
27. Chiantera V., Sarti C.D., Fornaro F., Farzati A., De Franciscis P., Sepe E., Borrelli A.L., Colacurci N. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels. Menopause. 10:2003;286.
28. Mendelsohn M.E., Karas R.H. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 340:1999;1801.
29. Mendelsohn M.E. Nongenomic, ER-mediated activation of endothelial nitric oxide synthase How does it work? What does it mean? Circ. Res. 87:2002;956.
30. Mendelsohn M.E. Genomic and non-genomic effects of estrogen in the vasculature. Am. J. Cardiol. 90:2002;F3.
31. Gerhard M., Walsh B.W., Tawakol A., Haley E.A., Creager S.J., Seeley E.W., Ganz P., Creager M.A. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation. 98:1998;1158.
32. McNeill A.M., Zhang C., Stanczyk F.Z., Duckles S.P., Krause D.N. Estrogen increases endothelial nitric oxide synthase via estrogen receptors in rat cerebral blood vessels. Stroke. 33:2002;1685.
33. Kawano H., Motoyama T., Hirai N., Yoshimura T., Kugiyama K., Ogawa H., Okamura H., Yasue H. Effect of medroxyprogesterone acetate plus estradiol on endothelium-dependent vasodilation in post-menopausal women. Am. J. Cardiol. 87:2001;238.